Export

ATC codes: L01CB01
EMLc
Indication
Retinoblastoma ICD11 code: 2D52.2
INN
Etoposide
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule
Oral > Solid: 100 mg capsule ; 50 mg capsule
EML status history
First added in 2015 (TRS 994)
Changed in 2019 (TRS 1021)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the addition of 50 mg strength formulation of etoposide capsules to the EML and EMLc.